Examkin

Soru

Zorluk: OrtaPatient Counseling and Health Education

A 65-year-old man presents to the ambulatory care office for a follow-up visit one week after being diagnosed with nonvalvular atrial fibrillation. His past medical history is also significant for severe chronic obstructive pulmonary disease. At his previous visit, he was prescribed apixaban for stroke prevention based on a CHA 2_2 DS 2_2-VASc score of 3. Today, the patient states, "I prefer to avoid synthetic medications whenever possible. I have been taking an over-the-counter St. John's wort supplement for the past year to help with occasional sadness. I would rather just take my supplement along with a daily aspirin instead of this new prescription." The patient is alert, fully oriented, and accurately describes the risks of untreated atrial fibrillation, but he expresses a strong personal distrust of pharmaceutical companies. Which of the following is the most appropriate physician response to educate and counsel this patient?

  1. St. John's wort can decrease the effectiveness of apixaban, increasing your risk of a stroke. Can we discuss your specific concerns about the new medication?Cevap
  2. B
    Because your condition carries a high risk of stroke, choosing to decline the recommended treatment indicates a lack of capacity to refuse care.
  3. C
    Since you are 65 years old, substituting the new medication with daily low-dose aspirin satisfies the preventive guidelines for stroke reduction.
  4. D
    St. John's wort is generally safe to take with apixaban; you may continue your current regimen as long as you attend regular follow-up visits.
  5. E
    We can switch your medication to a non-selective beta-blocker to prevent strokes, which avoids any interactions with your herbal supplement.

Cevap

The response that accurately informs the patient about the interaction between St. John's wort and apixaban while utilizing an open-ended question to explore his concerns.
The correct response effectively combines crucial health education with patient-centered communication. It directly addresses the dangerous pharmacokinetic interaction (St. John's wort induces CYP3A4 and P-glycoprotein, which increases the metabolism of apixaban and reduces its efficacy). At the same time, it avoids being coercive or judgmental. By following the medical fact with an open-ended question ("Can we discuss your specific concerns...?"), the physician invites the patient to elaborate on his distrust of synthetic medications, fostering a collaborative therapeutic alliance.

Adım Adım Çözüm

1
Assess the patient's decision-making capacity.
The patient is alert, oriented, and understands the risks of his condition and refusal.
Before compelling treatment or overriding autonomy, a physician must determine if the patient has capacity. Since capacity is intact, the patient has the right to refuse care.
2
Analyze the proposed medication regimen for safety and efficacy.
St. John's wort induces CYP3A4, which will lower apixaban efficacy. Aspirin is insufficient for stroke prevention in this patient.
Providing accurate health education requires identifying the dangerous pharmacokinetic interaction between the patient's supplement and the prescribed DOAC.
3
Select the optimal communication strategy.
Inform the patient of the specific interaction risk and ask an open-ended question to explore his distrust.
Effective counseling respects patient autonomy, provides essential safety information without being coercive, and uses motivational interviewing techniques to address the root cause of nonadherence.

Anahtar Kavram

Patient counseling requires addressing specific pharmacokinetic interactions (such as St. John's wort and CYP3A4 substrates) while simultaneously using open-ended questions to explore adherence barriers in patients with intact decision-making capacity.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Patient Counseling and Health Education

Bu konudan daha fazla soru